CSIMarket Company Name, Ticker, Industry, else..
 
Protagonist Therapeutics inc   (PTGX)
Other Ticker:  
 
 

Protagonist Therapeutics Inc Income Statement Quarterly

PTGX


Select the Financial Report:   Period:   Fiscal Year:

New: More PTGX's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Revenue From Contract With Customer Including Assessed Tax 4.17 254.95 - -
Revenue From Contract With Customer Product And Service Extensible List - - - -
Total Revenue 4.17 254.95 60.00 0.00 0.00
Cost of Revenues - - - - -
Gross Profit 4.17 254.95 60.00 0.00 0.00
Selling, Administration, Marketing 9.44 14.91 8.05 7.66 9.17
Depriciation & Amortization - - - - -
Research and Development Expense 33.52 33.73 28.90 30.66 33.18
Restructuring, Accretion & impairment charges - - - - -
Other operatinig exp. /-income - - - - -
Unusual Expense /-Income - - - - -
Total operating costs including COS 42.96 48.64 36.95 38.33 42.35
Operating income/-loss -38.79 206.31 23.05 -38.33 -42.35
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Investment Income, Interest - - - -4.25 -3.91
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -7.50 -4.36 -4.29 0.03 0.02
Total costs & expenses 35.46 44.29 32.67 34.11 38.46
Income /-loss before income taxes -31.29 210.67 27.34 -34.11 -38.46
Income taxes expenses/-benefit -0.68 3.33 - - -
Income after income taxes -30.62 207.34 27.34 -34.11 -38.46
Net income/-loss of other equity 0.00 - - - -
Income/-loss from cont. Ops. -30.62 207.34 27.34 -34.11 -38.46
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -30.62 207.34 27.34 -34.11 -38.46
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -30.62 207.34 27.34 -34.11 -38.46
EBIT -31.29 210.67 27.34 -34.11 -38.46
EBITD -31.05 210.90 27.58 -33.86 -38.22
EBITDA -31.05 210.90 27.58 -33.86 -38.22


Per Share (GAAP Quarterly, in $) (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Basic EPS (excl. extra items) -0.50 3.41 0.45 -0.58 -0.68
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.50 3.41 0.45 -0.58 -0.68
Basic shares outstanding (Mill. of Units) 61.31 60.86 60.52 59.18 56.78
   EPS other shares - - - - -
Diluted Net EPS -0.50 3.26 0.39 -0.58 -0.68
Diluted average shares (Mill. of Units) 61.31 63.60 56.80 59.18 56.78
Dividend per share - - - - -



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com